PDB Short entry for 2OSC HEADER TRANSFERASE 05-FEB-07 2OSC TITLE SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE TITLE 2 DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOPOIETIN-1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: TIE-2 KINASE DOMAIN; COMPND 5 SYNONYM: TYROSINE-PROTEIN KINASE RECEPTOR TIE-2, HTIE2, TYROSINE- COMPND 6 PROTEIN KINASE RECEPTOR TEK, P140 TEK, TUNICA INTERNA ENDOTHELIAL COMPND 7 CELL KINASE, CD202B ANTIGEN; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TEK, TIE2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE DOMAIN TIE-2, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.F.BELLON,J.KIM REVDAT 5 21-FEB-24 2OSC 1 REMARK REVDAT 4 04-APR-18 2OSC 1 REMARK REVDAT 3 24-FEB-09 2OSC 1 VERSN REVDAT 2 29-MAY-07 2OSC 1 JRNL REVDAT 1 20-MAR-07 2OSC 0 JRNL AUTH B.L.HODOUS,S.D.GEUNS-MEYER,P.E.HUGHES,B.K.ALBRECHT,S.BELLON, JRNL AUTH 2 S.CAENEPEEL,V.J.CEE,S.C.CHAFFEE,M.EMERY,J.FRETLAND, JRNL AUTH 3 P.GALLANT,Y.GU,R.E.JOHNSON,J.L.KIM,A.M.LONG,M.MORRISON, JRNL AUTH 4 P.R.OLIVIERI,V.F.PATEL,A.POLVERINO,P.ROSE,L.WANG,H.ZHAO JRNL TITL SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE JRNL TITL 2 DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 2886 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17350837 JRNL DOI 10.1016/J.BMCL.2007.02.067 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 8780 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.251 REMARK 3 FREE R VALUE : 0.306 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 433 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2705 REMARK 3 BIN FREE R VALUE : 0.3363 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 49 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1991 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 47 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OSC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041525. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8780 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.93 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14-18 % (W/V) PEG 3350, AND 0.2 M TRI REMARK 280 -POTASSIUM CITRATE (PH 6.5-7.5), AND 2% (V/V) ISOPROPANOL, PH REMARK 280 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 89.40700 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 31.49750 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 31.49750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 44.70350 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 31.49750 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 31.49750 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 134.11050 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 31.49750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 31.49750 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 44.70350 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 31.49750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 31.49750 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 134.11050 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 89.40700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 808 REMARK 465 ASN A 809 REMARK 465 ASN A 810 REMARK 465 PRO A 811 REMARK 465 ASP A 812 REMARK 465 PRO A 813 REMARK 465 THR A 814 REMARK 465 ILE A 815 REMARK 465 TYR A 816 REMARK 465 PRO A 817 REMARK 465 VAL A 818 REMARK 465 LEU A 819 REMARK 465 ASP A 820 REMARK 465 TRP A 821 REMARK 465 ASN A 822 REMARK 465 ASP A 823 REMARK 465 ILE A 824 REMARK 465 LYS A 825 REMARK 465 PHE A 826 REMARK 465 GLN A 827 REMARK 465 ASP A 828 REMARK 465 VAL A 829 REMARK 465 ILE A 830 REMARK 465 GLY A 831 REMARK 465 GLU A 832 REMARK 465 GLY A 833 REMARK 465 ASN A 834 REMARK 465 PHE A 835 REMARK 465 GLY A 836 REMARK 465 LYS A 844 REMARK 465 LYS A 845 REMARK 465 ASP A 846 REMARK 465 GLY A 847 REMARK 465 LEU A 848 REMARK 465 ARG A 849 REMARK 465 GLU A 859 REMARK 465 TYR A 860 REMARK 465 ALA A 861 REMARK 465 SER A 862 REMARK 465 ARG A 895 REMARK 465 GLY A 896 REMARK 465 TYR A 897 REMARK 465 LEU A 898 REMARK 465 SER A 986 REMARK 465 ARG A 987 REMARK 465 GLY A 988 REMARK 465 GLN A 989 REMARK 465 GLU A 990 REMARK 465 VAL A 991 REMARK 465 TYR A 992 REMARK 465 VAL A 993 REMARK 465 LYS A 994 REMARK 465 LYS A 995 REMARK 465 THR A 996 REMARK 465 ASP A 1117 REMARK 465 CYS A 1118 REMARK 465 SER A 1119 REMARK 465 ALA A 1120 REMARK 465 GLU A 1121 REMARK 465 GLU A 1122 REMARK 465 ALA A 1123 REMARK 465 ALA A 1124 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 837 CG CD OE1 NE2 REMARK 470 ARG A 842 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 843 CG1 CG2 CD1 REMARK 470 ARG A 856 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 858 CG CD CE NZ REMARK 470 LYS A 863 CG CD CE NZ REMARK 470 HIS A 894 CG ND1 CD2 CE1 NE2 REMARK 470 TYR A 899 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 916 CG CD CE NZ REMARK 470 LEU A 985 CG CD1 CD2 REMARK 470 MET A 997 CG SD CE REMARK 470 GLU A1058 CG CD OE1 OE2 REMARK 470 ARG A1099 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1109 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OH TYR A 976 OH TYR A 976 7646 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 923 82.74 -166.06 REMARK 500 ARG A 963 -16.35 76.34 REMARK 500 ASP A 964 46.14 -144.29 REMARK 500 ALA A 966 147.87 -174.48 REMARK 500 ASP A 982 104.70 -162.10 REMARK 500 GLU A1109 -71.09 -24.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MUH A 50 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OO8 RELATED DB: PDB REMARK 900 THIS ENTRY AND 2OO8 ARE BOTH DESCRIBED IN THE SAME PAPER. DBREF 2OSC A 808 1124 UNP Q02763 TIE2_HUMAN 808 1124 SEQRES 1 A 317 LYS ASN ASN PRO ASP PRO THR ILE TYR PRO VAL LEU ASP SEQRES 2 A 317 TRP ASN ASP ILE LYS PHE GLN ASP VAL ILE GLY GLU GLY SEQRES 3 A 317 ASN PHE GLY GLN VAL LEU LYS ALA ARG ILE LYS LYS ASP SEQRES 4 A 317 GLY LEU ARG MET ASP ALA ALA ILE LYS ARG MET LYS GLU SEQRES 5 A 317 TYR ALA SER LYS ASP ASP HIS ARG ASP PHE ALA GLY GLU SEQRES 6 A 317 LEU GLU VAL LEU CYS LYS LEU GLY HIS HIS PRO ASN ILE SEQRES 7 A 317 ILE ASN LEU LEU GLY ALA CYS GLU HIS ARG GLY TYR LEU SEQRES 8 A 317 TYR LEU ALA ILE GLU TYR ALA PRO HIS GLY ASN LEU LEU SEQRES 9 A 317 ASP PHE LEU ARG LYS SER ARG VAL LEU GLU THR ASP PRO SEQRES 10 A 317 ALA PHE ALA ILE ALA ASN SER THR ALA SER THR LEU SER SEQRES 11 A 317 SER GLN GLN LEU LEU HIS PHE ALA ALA ASP VAL ALA ARG SEQRES 12 A 317 GLY MET ASP TYR LEU SER GLN LYS GLN PHE ILE HIS ARG SEQRES 13 A 317 ASP LEU ALA ALA ARG ASN ILE LEU VAL GLY GLU ASN TYR SEQRES 14 A 317 VAL ALA LYS ILE ALA ASP PHE GLY LEU SER ARG GLY GLN SEQRES 15 A 317 GLU VAL TYR VAL LYS LYS THR MET GLY ARG LEU PRO VAL SEQRES 16 A 317 ARG TRP MET ALA ILE GLU SER LEU ASN TYR SER VAL TYR SEQRES 17 A 317 THR THR ASN SER ASP VAL TRP SER TYR GLY VAL LEU LEU SEQRES 18 A 317 TRP GLU ILE VAL SER LEU GLY GLY THR PRO TYR CYS GLY SEQRES 19 A 317 MET THR CYS ALA GLU LEU TYR GLU LYS LEU PRO GLN GLY SEQRES 20 A 317 TYR ARG LEU GLU LYS PRO LEU ASN CYS ASP ASP GLU VAL SEQRES 21 A 317 TYR ASP LEU MET ARG GLN CYS TRP ARG GLU LYS PRO TYR SEQRES 22 A 317 GLU ARG PRO SER PHE ALA GLN ILE LEU VAL SER LEU ASN SEQRES 23 A 317 ARG MET LEU GLU GLU ARG LYS THR TYR VAL ASN THR THR SEQRES 24 A 317 LEU TYR GLU LYS PHE THR TYR ALA GLY ILE ASP CYS SER SEQRES 25 A 317 ALA GLU GLU ALA ALA HET MUH A 50 33 HETNAM MUH N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL) HETNAM 2 MUH AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE FORMUL 2 MUH C24 H18 F3 N5 O FORMUL 3 HOH *47(H2 O) HELIX 1 1 LYS A 863 GLY A 880 1 18 HELIX 2 2 ASN A 909 SER A 917 1 9 HELIX 3 3 ARG A 918 ASP A 923 1 6 HELIX 4 4 ASP A 923 SER A 931 1 9 HELIX 5 5 SER A 937 GLN A 957 1 21 HELIX 6 6 ALA A 966 ARG A 968 5 3 HELIX 7 7 GLU A 974 TYR A 976 5 3 HELIX 8 8 PRO A 1001 MET A 1005 5 5 HELIX 9 9 ALA A 1006 SER A 1013 1 8 HELIX 10 10 THR A 1016 SER A 1033 1 18 HELIX 11 11 THR A 1043 LEU A 1051 1 9 HELIX 12 12 PRO A 1052 GLY A 1054 5 3 HELIX 13 13 ASP A 1064 TRP A 1075 1 12 HELIX 14 14 LYS A 1078 ARG A 1082 5 5 HELIX 15 15 SER A 1084 GLU A 1098 1 15 SHEET 1 A 4 VAL A 838 ALA A 841 0 SHEET 2 A 4 ALA A 852 LYS A 855 -1 O ILE A 854 N LEU A 839 SHEET 3 A 4 LEU A 900 GLU A 903 -1 O LEU A 900 N LYS A 855 SHEET 4 A 4 LEU A 888 ALA A 891 -1 N GLY A 890 O ALA A 901 SHEET 1 B 2 ILE A 970 GLY A 973 0 SHEET 2 B 2 VAL A 977 ILE A 980 -1 O LYS A 979 N LEU A 971 SITE 1 AC1 14 LYS A 855 GLU A 872 LEU A 876 LEU A 879 SITE 2 AC1 14 ILE A 902 TYR A 904 ALA A 905 PHE A 960 SITE 3 AC1 14 HIS A 962 LEU A 971 ILE A 980 ALA A 981 SITE 4 AC1 14 ASP A 982 PHE A 983 CRYST1 62.995 62.995 178.814 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015874 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015874 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005592 0.00000